Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Role of CYP2B6, CYP3A4, and MDR1 in the Metabolic Clearance of Methadone
This study is currently recruiting participants.
Study NCT00504413 Information provided by University of Washington
First Received: July 18, 2007 Last Updated: August 20, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Substance-Related Disorders
More general conditions related to this trial
Disorders of Environmental Origin
Mental Disorders
Interventions listed in this trial
midazolam(drug), digoxin (drug)
Bupropion (drug)
Methadone (drug)
Additional drug interventions recognized in this trial
Bupropion
Methadone
Midazolam
More general drug interventions related to this trial
Adjuvants, Anesthesia
Analgesics
Analgesics, Opioid
Anesthetics
Anesthetics, General
Anesthetics, Intravenous
Anti-Anxiety Agents
Antidepressive Agents
Antidepressive Agents, Second-Generation
Antitussive Agents
Central Nervous System Agents
Central Nervous System Depressants
Dopamine Agents
Dopamine Uptake Inhibitors
GABA Agents
GABA Modulators
Hypnotics and Sedatives
Molecular Mechanisms of Pharmacological Action
Narcotics
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Respiratory System Agents
Sensory System Agents
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
University of Washington
Back to top of Main Content
